First Patient Treated in Spine BioPharma Phase III Clinical Study

The first patient has been treated in a U.S. Phase III clinical study of Spine BioPharma's SB-01 For Injection. The SB-01 Phase III study is known as MODEL (Moderate – Severe Degenerative Disc Disease Evaluation of the Lumbar Spine). SB-01 is said to be the first intradiscal pharmacologic treatment to enter Phase III studies for the treatment of...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us